Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Public Health ; 173: 146-149, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31310874

RESUMO

OBJECTIVES: To evaluate the effectiveness of the implementation of the adolescent package of care (APOC) training on adolescent viral suppression at Family AIDS Care & Education Services (FACES)-supported sites. STUDY DESIGN: The effect of APOC training was evaluated based on viral load suppression (<1000 copies/mL) of 10-19-year-olds in 13 FACES-supported sites in six months before (January 2015-August 2016) and after (November 2015-March 2017) the APOC training for each site. METHODS: Patient-level data were abstracted from the FACES electronic medical records (OpenMRS) and the National AIDS and STI Control Programme viral load website. Information on adolescent clinic day implementation and utilization of an APOC checklist as a proxy for services provided at each site was collected. Generalized estimating equations with repeated measures clustered by patients were used for bivariate and multivariate modeling to assess factors associated with viral suppression. RESULTS: In the pretraining period, 60% of adolescents received services at clinics offering adolescent clinic days compared to 95% in the post-training period. Among those tested, 65% were virally suppressed during the pretraining period compared to 72% during the post-training period (odds ratio [OR] = 1.31, 95% confidence interval [CI] 1.12, 1.53, P < 0.01). In multivariable analysis, there was no statistically significant change in viral load suppression due to APOC training (adjusted OR [aOR] = 0.97, 95% CI: 0.72, 1.30, P = 0.84). However, at clinics offering adolescent-friendly clinic days, adolescents were nearly 2 times more likely to be virally suppressed than at facilities not offering these specialized clinic days (aOR = 1.86, 95% CI: 1.04, 3.32, P = 0.04). CONCLUSIONS: This study suggests that adolescent clinic days greatly improve adolescent viral load suppression and should be considered for implementation across HIV programs.


Assuntos
Infecções por HIV/terapia , Educação de Pacientes como Assunto , Carga Viral/estatística & dados numéricos , Adolescente , Feminino , Seguimentos , Humanos , Quênia , Masculino , Avaliação de Programas e Projetos de Saúde
2.
AIDS Behav ; 22(9): 2956-2965, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29948337

RESUMO

A rapid results initiative (RRI) aimed at increasing male involvement in prevention of mother-to-child transmission (PMTCT) and service uptake among pregnant women at 116 antenatal clinics in Western Kenya was compared at baseline, during the RRI, and 3-months post-RRI. Male involvement increased from 7.4 to 54.2% during RRI (risk difference [RD] 0.47, CI 0.45-0.48) then 43.4% post-RRI (RD 0.36, CI 0.35-0.37). Among HIV-infected women, facility delivery increased from 40.0 to 49.9% (RD 0.10, 95% CI 0.06-0.13) and 65.0% post-RRI (RD 0.25, 95% CI 0.22-0.28). HIV-infected pregnant women linkage to HIV care increased from 58.6 to 85.9% (RD 0.27, CI 0.24-0.30) and 97.3% post-RRI (RD 0.39, CI 0.36-0.41). Time to ART initiation reduced from 29 days (interquartile range [IQR] 6-56) to 14 days (IQR 0-28) to 7 days (IQR 0-20). A male-centered RRI can significantly increase men's engagement in antenatal care leading to improved partner utilization of PMTCT and antenatal services.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Atenção à Saúde , Infecções por HIV/prevenção & controle , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Complicações Infecciosas na Gravidez/tratamento farmacológico , Cuidado Pré-Natal , Cônjuges , Adulto , Parto Obstétrico/estatística & dados numéricos , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/transmissão , Humanos , Quênia , Masculino , Gravidez , Parceiros Sexuais , Adulto Jovem
3.
East Afr Med J ; 89(2): 45-52, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26845811

RESUMO

BACKGROUND: An accurate estimation of renal function in children is important in optimising the dose of many drugs used in paediatric oncology for allowing clinical monitoring of the nephrotoxic effects of cytotoxic agents such as cisplatin. The glomerular filtration rate (GFR) is widely accepted as the best index of renal function in patients. Chemotherapy is the mainstay of treatment in the paediatric oncology unit at the Kenyatta National Hospital. OBJECTIVES: To determine the glomerular filtration rate profiles of paediatric oncology patients and to assess changes that had occured over a period of at least six months of continuing cancer chemotherapy. DESIGN: Cross-sectional hospital based survey. SETTING: General Paediatric wards, including Paediatric Oncology and Paediatric Ophthalmology ward. Kenyatta National Hospital, Nairobi, Kenya. Subjects: Paediatric patients who had an established diagnosis of cancer and had been on chemotherapy for at least six months. RESULTS: Out of the 115 children enrolledin the study 43 had abnormal kidney function, This gave a prevalence of 37% (95% CI 28-46).The other 72 children had normal kidney function. Patients aged less than five years and those with solid tumors had a higher likelihood of having an abnormal GFR compared to their older counterparts and thosc with-lymphomas and leukemias. CONCLUSIONS: Monitoring of GFR should be done regularly as decline occurs as one continues on chemotherapy especially for the ones below five years and those witl solid malignancies.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Taxa de Filtração Glomerular , Nefropatias/induzido quimicamente , Nefropatias/diagnóstico , Fatores Etários , Antineoplásicos Alquilantes/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Carboplatina/efeitos adversos , Criança , Pré-Escolar , Cisplatino/efeitos adversos , Estudos Transversais , Feminino , Taxa de Filtração Glomerular/efeitos dos fármacos , Hospitais Universitários , Humanos , Incidência , Quênia/epidemiologia , Nefropatias/epidemiologia , Nefropatias/fisiopatologia , Masculino , Valor Preditivo dos Testes , Prevalência , Prognóstico , Fatores de Risco , Sensibilidade e Especificidade
4.
Int J Tuberc Lung Dis ; 12(3 Suppl 1): 63-8, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18302825

RESUMO

SETTING: Integrated tuberculosis (TB) and human immunodeficiency virus (HIV) services in a resource-constrained setting. OBJECTIVE: Pilot provider-initiated HIV testing and counselling (PITC) for TB patients and suspects. DESIGN: Through partnerships, resources were mobilised to establish and support services. After community sensitisation and staff training, PITC was introduced to TB patients and then to TB suspects from December 2003 to December 2005. RESULTS: Of 5457 TB suspects who received PITC, 89% underwent HIV testing. Although not statistically significant, TB suspects with TB disease had an HIV prevalence of 61% compared to 63% for those without. Of the 614 suspects who declined HIV testing, 402 (65%) had TB disease. Of 2283 patients referred for cotrimoxazole prophylaxis, 1951 (86%) were enrolled, and of 1727 patients assessed for antiretroviral treatment (ART), 1618 (94%) were eligible and 1441 (83%) started treatment. CONCLUSIONS: PITC represents a paradigm shift and is feasible and acceptable to TB patients and TB suspects. Clear directives are nevertheless required to change practice. When offered to TB suspects, PITC identifies large numbers of persons requiring HIV care. Community sensitisation, staff training, multitasking and access to HIV care contributed to a high acceptance of HIV testing. Kenya is using this experience to inform national response and advocate wide PITC implementation in settings faced with the TB-HIV epidemic.


Assuntos
Prestação Integrada de Cuidados de Saúde/organização & administração , Aconselhamento Diretivo , Infecções por HIV/diagnóstico , Tuberculose/complicações , Sorodiagnóstico da AIDS , Fármacos Anti-HIV/uso terapêutico , Anti-Infecciosos/uso terapêutico , Infecções por HIV/complicações , Infecções por HIV/terapia , Humanos , Quênia/epidemiologia , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Projetos Piloto , Prevalência , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Tuberculose/diagnóstico , Tuberculose/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...